About us

Levo Pharma Co., Ltd. is a leading global specialty generic pharmaceutical company focused in high-quality, affordable medicines to more than 27 countries worldwide. Our products are trusted by healthcare professionals and patients.

Diversified Specialty and Generics Portfolio

We produce and market a wide range of pharmaceutical products that encompass various chronic and acute treatments.

Our offerings include generic and branded medications, as well as specialized, technologically advanced products that are challenging to manufacture. This encompasses over-the-counter (OTC) medications, Active Pharmaceutical Ingredients (APIs), and Intermediates.

Our extensive portfolio comprises high-quality molecules, spanning multiple dosage forms such as tablets, capsules, injectables and liquids. Annually, we distribute over 30 billion doses, catering to areas such as androgenic hormones, cardiology, diabetics, growth hormones, diabetology, oncology, urology, asthmatics among others.

Driven by Innovation

The first among Indian pharmaceutical companies to realize and embrace the importance of investing in research, we invest up to 7-8% of our global revenues into Research and Development (R&D) every year.

Our core strength lies in our ability to excel in developing generics and technologically complex products backed by our dedicated teams in formulations, process chemistry, and analytical development.

Our capabilities extend beyond the development of differentiated products, including tablets products, water solution, lyophilized injections, oil injectables, and controlled release dosage forms.

Global Footprint

From its modest origins in 2003, Levo Pharma has evolved into one of the largest generic pharmaceutical companies globally.

It holds the position of the largest pharmaceutical company in India. In the US, it ranks among the top 10 generic pharmaceutical companies and is the second highest in terms of prescriptions in the generic medicines. Levo Pharma is also the largest Indian company in emerging markets, with a presence in over 80 markets, including key markets such as Brazil, Mexico, Russia, Romania, and South Africa.